Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis

Neoplasia

Volumn 10, Issue 1, 2008, Pages 41-51

  Cai, Jun ^a   Niu, Xin ^a   Chen, Yuying ^a   Hu, Qingshen ^a   Shi, Guiying ^a   Wu, Huacheng ^a   Wang, Jian ^b   Yi, Jing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ARSENIC TRIOXIDE; EMODIN; F ACTIN; REACTIVE OXYGEN METABOLITE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANOIKIS; APOPTOSIS; ARTICLE; CANCER CELL; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; FOCAL ADHESION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; STOMACH CARCINOMA; STOMACH MUCOSA; UPREGULATION;

EID: 38649089487     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07754     Document Type: Article

References (56)

1. Hall A (1998). RhoA GTPases and the actin cytoskeleton. Science 279, 509-514.
2. Ridley AJ (2001). Rho family proteins: coordinating cell responses. Cancer Metastasis Rev 11, 471-477.
3. Coleman ML and Olson MF (2002). Rho GTPase signaling pathways in the morphological changes associated with apoptosis. Cell Death Differ 9, 493-504.
4. Etienne-Manneville S and Hall A (2002). Rho GTPases in cell biology. Nature 420, 629-635.
5. Vega FM and Ridley AJ (2007). SnapShot: Rho Family GTPases. Cell 129, 1430-1431.
6. Aznar S, Fernandez-Valeron P, Espina C, and Lacal JC (2004). Rho GTPases: potential candidates for anticancer therapy. Cancer Lett 206, 181-191.
7. Fritz G, Brachetti C, Bahlmann F, Schmidt M, and Kaina B (2002). Rho GTPases in human breast tumors: expression and mutation analyses and correlation with clinical parameters. Br J Cancer 87, 635-644.
8. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y, and Oshima H (2003). Significant association of Rho/ROCK pathway with invasion and metastasis of bladder. Clin Cancer Res 9, 2632-2641.
9. Horiuchi A, Imai T, Wang C, Ohira S, Feng Y, Nikaido T, and Konishi I (2003). Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 83, 861-870.
10. Ridley AJ (2004). Rho proteins and cancer. Breast Cancer Res Treat 84, 13-19.
11. Liberto M, Cobrinik D, and Minden A (2002). Rho regulates p21(CIP1), cyclin D, and checkpoint control in mammary epithelial cells. Oncogene 21, 1590-1599.
12. Vidal A, Millard SS, Miller JP, and Koff A (2002). Rho activity can alter the translation of p27 mRNA and is important for RasV122 induced transformation in a manner dependent on p27 status. J Biol Chem 277, 16433-16440.
13. Liu CA, Wang MJ, Chi CW, Wu CW, and Chen JY (2004). Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis. Oncogene 23, 8731-8742.
14. Hagmann J, Burger MM, and Dagan D (1999). Regulation of plasma membrane blebbing by the cytoskeleton. J Cell Biochem 73, 488-499.
15. Riento K and Ridley AJ (2003). ROCKS: multifunctional kinases in cell behaviour. Nature Rev Mol Biol Cell 4, 446-456.
16. Frisch SM and Screaton RA (2001). Anoikis mechanisms. Curr Opin Cell Biol 13, 555-562.
17. Reddig PJ and Juliano RL (2005). Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev 24, 425-439.
18. Evan GI and Vousden KH (2001). Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342-348.
19. Eccles SA and Welch DR (2007). Metastasis: recent discoveries and novel treatment strategies. Lancet 369, 1742-1757.
20. Rosen K, Rak J, Leung T, Dean NM, Kerbel RS, and Filmus J (2000). ROCKS: multifunctional kinases in cell behaviour. J Cell Biol 149, 447-456.
21. Mitra SK, Hanson DA, and Schlaepfer DD (2005). Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6, 56-68.
22. Brown MC and Turner CE (2004). Paxillin: adapting to change. Physiol Rev 84, 1315-1339.
23. Gilmore AP (2005). Anoikis. Cell Death Differ 12, 1473-1477.
24. Ziegler WH, Liddington RC, and Critchley DR (2006). The structure and regulation of vinculin. Trends Cell Biol 16, 453-460.
25. Attwell S, Roskelley C, and Dedhar S (2000). The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19, 3811-3815.
26. Parson JT (2003). Focal adhesion kinase: the first ten years. J Cell Sci 116, 1409-1416.
27. Legate KR, Montañez E, Kudlacek O, and Fässler R (2006). ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 7, 20-31.
28. Mitra SK and Schlaepfer DD (2006). Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18, 516-523.
29. Chen Z, Chen GQ, Shen ZX, Chen SJ, and Wang ZY (2001). Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies. Semin Hematol 38, 26-36.
30. Maeda H, Hori S, Ohizumi H, Segawa T, Kakehi Y, Ogawa O, and Kakizuka A (2004). Effective treatment of advanced solid tumors by the combination of arsenic trioxide and l-buthionine-sulfoximine. Cell Death Differ 11, 737-746.
31. Yi J, Yang J, He R, Gao F, Sang H, Tang X, and Ye RD (2004). Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Res 64, 108-116.
32. Yang J, Li H, Chen YY, Wang XJ, Shi GY, Hu QS, Kang XL, Lu Y, Tang XM, Guo QS, et al. (2004). Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species mediated dual regulation of apoptosis. Free Radic Biol Med 37, 2027-2041.
33. Jing Y, Yang J, Wang Y, Li H, Chen Y, Hu Q, Shi G, Tang X, and Yi J (2006). Alteration of subcellular redox equilibrium and the consequent oxidative modification of nuclear factor ?B are critical for anticancer cytotoxicity by emodin, a reactive oxygen species-producing agent. Free Radic Biol Med 40, 2183-2197.
34. Heo J, Raines KW, Mocanu V, and Campbell SL (2006). Redox regulation of RhoA. Biochemistry 45, 14481-14489.
35. Kajimoto H, Hashimoto K, Bonnet SN, Haromy A, Harry G, Moudgil R, Nakanishi T, Rebeyka I, Thébaud B, Michelakis ED, et al. (2007). Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction. Circulation 115, 1777-1788.
36. 1/S transition of human gastric cells SGC7901 and AGS. FASEB J 21, 2247-2256.
37. Wang Q, Huang Y, Ni Y, Wang H, and Hou Y (2007). siRNA targeting midkine inhibits gastric cancer cells growth and induces apoptosis involved caspase-3,8,9 activation and mitochondrial depolarization. J Biomed Sci 14, 783-795.
38. Horiuchi A, Imai T, Wang C, Ohira S, Feng Y, Nikaido T, and Konishi I (2003). Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 83, 861-870.
39. Aida J, Izumiyama-Shimomura N, Nakamura K, Ishii A, Ishikawa N, Honma N, Kurabayashi R, Kammori M, Poon SS, Arai T, et al. (2007). Telomere length variations in 6 mucosal cell types of gastric tissue observed using a novel quantitative fluorescence in situ hybridization method. Hum Pathol 38, 1192-1200.
40. Shepard LW, Yang M, Xie P, Browning DD, Voyno-Yasenetskaya T, Kozasa T, and Ye RD (2001). Constitutive activation of NF-kappa B and secretion of interleukin-8 induced by the G protein-coupled receptor of Kaposi's sarcoma - associated herpesvirus involve G alpha(13) and RhoA. J Biol Chem 276, 45979-45987.
41. Huang S, Chen LY, Zuraw BL, Ye RD, and Pan ZK (2001). Chemoattractant-stimulated NF-κB activation is dependent on the low molecular weight GTPase RhoA. J Biol Chem 276, 40977-40981.
42. Kang HG, Jenabi JM, Zhang J, Keshelava N, Shimada H, May WA, Ng T, Reynolds CP, Triche TJ, and Sorensen PH (2007). E-cadherin cell-cell adhesion in Ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res 67, 3094-3105.
43. Chimini G and Chavrier P (2000). Function of Rho family proteins in actin dynamics during phagocytosis and engulfment. Nat Cell Biol 2, E191-E196.
44. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, and Horwitz AF (2004). FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6, 154-161.
45. Frisch SM and Ruoslahti E (1997). Integrins and anoikis. Curr Opin Cell Biol 9, 701-706.
46. Horowitz JC, Rogers DS, Sharma V, Vittal R, White ES, Cui Z, and Thannickal VJ (2007). Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal 19, 761-771.
47. Toruner M, Fernandez-Zapico M, Sha JJ, Pham L, Urrutia R, and Egan LJ (2006). Antianoikis effect of nuclear factor-kappaB through up-regulated expression of osteoprotegerin, BCL-2, and IAP-1. J Biol Chem 281, 8686-8696.
48. Cheng TL, Symons M, and Jou TS (2004). Regulation of anoikis by Cdc42 and Rac1. Exp Cell Res 295, 497-511.
49. Miñambres R, Guasch RM, Perez-Aragó A, and Guerri C (2006). The RhoA/ROCK-I/MLC pathway is involved in the ethanol-induced apoptosis by anoikis in astrocytes. J Cell Sci 119, 271-282.
50. Ridley AJ (2006). Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 16, 522-529.
51. Fritz G and Kaina B (2006). Rho GTPases: promising cellular targets for novel anticancer drugs. Curr Cancer Drug Targets 6, 1-14.
52. Dai J, Weinberg RS, Waxman S, and Jing Y (1999). Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93, 268-277.
53. Yi J, Gao F, Shi G, Li H, Wang Z, Shi X, and Tang X (2002). The inherent cellular level of reactive oxygen species: one of the mechanisms determining apoptotic susceptibility of leukemic cells to arsenic trioxide. Apoptosis 7, 209-215.
54. Friesen C, Kiess Y, and Debatin KM (2004). A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells. Cell Death Differ 11 (Suppl 1), S73-S85.
55. Li AE, Ito H, Rovira II, Kim KS, Takeda K, Yu ZY, Ferrans VJ, and Finkel T (1999). A role for reactive oxygen species in endothelial cell anoikis. Circ Res 85, 304-310.
56. Kang WK, Lee I, Ko U, and Park C (2005). Differential effects of RhoA signaling on anticancer agent-induced cell death. Oncol Rep 13, 299-304.